Some Lingering Controversies Confront Bruce Alberts As He Succeeds Frank Press At National Academy Helm

Editor's Note: This article, which discusses the legacy left to new National Academy of Sciences president Bruce Alberts by his predecessor, Frank Press, is the second part of a two- part series. The first part, which appeared in the June 28, 1993, issue, dealt with Alberts's plans for the academy. The new NAS president may have to deal with sensitive issues that some members consider not fully resolved As Bruce M. Alberts settles into the president's office at the National Academy of S

Written byBarbara Spector
| 14 min read

Register for free to listen to this article
Listen with Speechify
0:00
14:00
Share

"You need a lot of information to run this organization well," says the molecular biologist, who assumed the presidency July 1.

Among the things Alberts undoubtedly will be contemplating is the legacy left by his predecessor, Frank Press, a geophysicist who has joined the Carnegie Institution of Washington, D.C., as the Cecil and Ida Green Senior Fellow. Several academy members contacted for this article say that legacy is, for better or worse, a sizable one indeed.

Press's tenure, they say, was extraordinarily productive, marked as it was by a strengthening of the National Research Council, considerable growth in the academy's endowment fund, and a widening of the range of constituents the academy represents. Yet his term has not been free from controversy; there have been several noteworthy instances in which opposition has arisen from within the membership to a course of action he took.

Some of the issues that came ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies